Literature DB >> 25744138

Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study.

Karsten Bartels1, Yi-Ju Li, Yen-Wei Li, William D White, Daniel T Laskowitz, Miklos D Kertai, Mark Stafford-Smith, Mihai V Podgoreanu, Mark F Newman, Joseph P Mathew.   

Abstract

PURPOSE: Cognitive performance after cardiac surgery can be impaired, and genetic risk factors have previously been suggested. When compared with other isoforms of the gene, the apolipoprotein epsilon 4 (APOE4) allele is associated with worse outcomes in many neurologic disorders. We hypothesized that the APOE4 allele is associated with less favourable cognitive function five years after surgery.
METHODS: Caucasian patients enrolled in previously reported prospective cognitive trials in both cardiac and non-cardiac surgery participated in this retrospective cohort study. Neuropsychological function was assessed at baseline and five years postoperatively. The relationship between change in cognitive index score and APOE was evaluated using multivariable linear regression. An additive genetic model toward the epsilon 4 allele was applied with adjustment for baseline cognition, years of education, age, presence of diabetes in both cohorts, and presence of coronary artery disease in the non-cardiac surgery cohort.
RESULTS: A total of 357 patients were included in this study. In the cardiac surgery group (n = 233), baseline cognitive index (P < 0.001), years of education (P = 0.04), age at time of surgery (P < 0.001), and the APOE4 allele (P = 0.009), were associated with a five-year change in cognitive index. Patients carrying the APOE4 allele showed less improvement in cognitive index scores five years after cardiac surgery compared with patients without the APOE4 allele. In the non-cardiac surgery (n = 124) group, no association was found between APOE4 allele status and change in cognitive index.
CONCLUSION: We report an association between APOE4 and neurocognitive function five years following cardiac surgery. Preoperative identification of patients with the APOE4 genotype may improve stratification of cardiac surgery patients at risk for a less favourable cognitive trajectory.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25744138      PMCID: PMC4529992          DOI: 10.1007/s12630-015-0337-8

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  36 in total

1.  Apolipoprotein E polymorphisms and age at first coronary artery bypass graft.

Authors:  M F Newman; D T Laskowitz; W D White; J L Kirchner; H P Grocott; M Stafford-Smith; M H Sketch; R H Jones; J G Reves; A M Saunders
Journal:  Anesth Analg       Date:  2001-04       Impact factor: 5.108

2.  Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients.

Authors:  Lian K Ti; G Burkhard Mackensen; Hilary P Grocott; Daniel T Laskowitz; Barbara G Phillips-Bute; Carmelo A Milano; Andrew K Hilton; Mark F Newman; Joseph P Mathew
Journal:  J Thorac Cardiovasc Surg       Date:  2003-01       Impact factor: 5.209

3.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

4.  Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery.

Authors:  Hilary P Grocott; G Burkhard Mackensen; Alina M Grigore; Joseph Mathew; J G Reves; Barbara Phillips-Bute; Peter K Smith; Mark F Newman
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

5.  Apolipoprotein E4 potentiates amyloid beta peptide-induced lysosomal leakage and apoptosis in neuronal cells.

Authors:  Zhong-Sheng Ji; R Dennis Miranda; Yvonne M Newhouse; Karl H Weisgraber; Yadong Huang; Robert W Mahley
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

6.  The role of apolipoprotein E in cognitive decline after cardiac operation.

Authors:  L Steed; R Kong; J Stygall; J Acharya; M Bolla; M J Harrison; S E Humphries; S P Newman
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

7.  The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery.

Authors:  Alina M Grigore; Hilary P Grocott; Joseph P Mathew; Barbara Phillips-Bute; Timothy O Stanley; Aimee Butler; Kevin P Landolfo; Joseph G Reves; James A Blumenthal; Mark F Newman
Journal:  Anesth Analg       Date:  2002-01       Impact factor: 5.108

Review 8.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

9.  Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls.

Authors:  Ola A Selnes; Maura A Grega; Louis M Borowicz; Richard M Royall; Guy M McKhann; William A Baumgartner
Journal:  Ann Thorac Surg       Date:  2003-05       Impact factor: 4.330

10.  Apolipoprotein E controls the risk and age at onset of Parkinson disease.

Authors:  Y J Li; M A Hauser; W K Scott; E R Martin; M W Booze; X J Qin; J W Walter; M A Nance; J P Hubble; W C Koller; R Pahwa; M B Stern; B C Hiner; J Jankovic; C G Goetz; G W Small; F Mastaglia; J L Haines; M A Pericak-Vance; J M Vance
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

View more
  8 in total

1.  Perioperative neurocognitive and functional neuroimaging trajectories in older APOE4 carriers compared with non-carriers: secondary analysis of a prospective cohort study.

Authors:  Jeffrey N Browndyke; Mary C Wright; Rosa Yang; Ayesha Syed; John Park; Ashley Hall; Katherine Martucci; Michael J Devinney; Leslie Shaw; Teresa Waligorska; Eugene W Moretti; Heather E Whitson; Harvey J Cohen; Joseph P Mathew; Miles Berger
Journal:  Br J Anaesth       Date:  2021-09-14       Impact factor: 9.166

Review 2.  An Update on Postoperative Cognitive Dysfunction Following Cardiac Surgery.

Authors:  Tony Vu; Julian A Smith
Journal:  Front Psychiatry       Date:  2022-06-15       Impact factor: 5.435

3.  The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.

Authors:  Keith W VanDusen; Sarada Eleswarpu; Eugene W Moretti; Michael J Devinney; Donna M Crabtree; Daniel T Laskowitz; Marty G Woldorff; Kenneth C Roberts; John Whittle; Jeffrey N Browndyke; Mary Cooter; Frank W Rockhold; Oke Anakwenze; Michael P Bolognesi; Mark E Easley; Michael N Ferrandino; William A Jiranek; Miles Berger
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

4.  Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice.

Authors:  Katie J Schenning; Sarah Holden; Brett A Davis; Amelia Mulford; Kimberly A Nevonen; Joseph F Quinn; Jacob Raber; Lucia Carbone; Nabil J Alkayed
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

5.  Apolipoprotein E ε4 and cognitive function after surgery in middle-aged and elderly Danish twins.

Authors:  Unni Dokkedal; Mette Wod; Mikael Thinggaard; Tom G Hansen; Lars S Rasmussen; Kaare Christensen; Jonas Mengel-From
Journal:  Eur J Anaesthesiol       Date:  2020-11       Impact factor: 4.183

Review 6.  Cognitive function in patients with coronary artery disease: A literature review.

Authors:  J Burkauskas; P Lang; A Bunevičius; J Neverauskas; M Bučiūtė-Jankauskienė; N Mickuvienė
Journal:  J Int Med Res       Date:  2018-08-29       Impact factor: 1.671

7.  Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy.

Authors:  Paul J Orchard; Todd W Markowski; LeeAnn Higgins; Gerald V Raymond; David R Nascene; Weston P Miller; Elizabeth I Pierpont; Troy C Lund
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

8.  Current Neurologic Assessment and Neuroprotective Strategies in Cardiac Anesthesia: A Survey to the Membership of the Society of Cardiovascular Anesthesiologists.

Authors:  Martin Krause; Joseph E Morabito; G Burkhard Mackensen; Tjörvi E Perry; Karsten Bartels
Journal:  Anesth Analg       Date:  2020-08       Impact factor: 6.627

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.